To address this, Guo and colleagues developed a bifunctional micelle (Pep-1/Bor/CMS-M) aimed at treating gliomas by utilizing Pep-1 to target overexpressed IL-13R and incorporating borneol to enhance the blood–brain barrier penetration [166]. Here, IL13RA2 is linked to central nervous system cancer.